Brought to you by 
BioMimetic grosses $8mm via private financing
15 Apr 2009
Executive Summary
Orthopedics company BioMimetic Therapeutics grossed $8mm through the private placement of 941,177 common shares at $8.50 each (a 9% premium) to InterWest Partners. Concurrently the company announced plans to commence a rights offering of up to $17mm, in which current investor Novo AS will buy as much as $15mm in common stock (at $8.50 per share) if other existing shareholders do not participate.
Deal Industry
- Pharmaceuticals
-
Medical Devices
- Biomaterials
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Private Investment in Public Equity
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
BioMimetic grosses $8mm via private financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice